Phoenix Molecular is developing and integrating three disruptive technologies into a single system to disrupt the market in molecular testing
The simple, cost-effective and fully-integrated system can be utilized in military, industrial, public health, and human and veterinary diagnostics markets
Funding: Secured Spring TECS S$500k & NRF-TIS S$500k
AITventures incubation services: Acting COO, support for business plan development and grant writing, providing incubation space, corporate secretary, financial, admin and HR support
HEALTHSEQ ASIA PTE LTD
HealthSeq Asia was founded with the vision of being the leading genome analysis cloud computing company in Asia.
The HealthSeq product will serve as a platform for delivering genome-driven personalized medicine, optimization of healthcare provision, and management and analyses of patient genomic data, clinical trials and pharmaceutical data.
Product verification and validation: Software & infrastructure development at Center for Precision & Personalised Medicine at NUHS.
Funding: Secured Spring TECS S$500k.
AITventures incubation services: Acting COO, support for business plan, product development and grant writing, providing incubation space, corporate secretary, financial, admin and HR support.
AIT Technologies (AIT) is providing information and communications technologies (ICT), largely focussed on interactive automated machines and self-service kiosks.
Core technologies licensed from local institutions are applied into the company products like DigiQuin™(Retail), First Legitimated Auto Check-in/out Kiosk (Hospitality) and Self Health-screening Kiosk (Licensed Content via public health operator) with highly disruptive growing potential.
AIT’s self-service products and solutions are widely used in Retails, F&B, Healthcare, Hospitality, Payment, public services and ticketing.
Funding: Various Spring assistance through the years, Revenue > $250,000
AITventures incubation services: Assisted in IP negotiations with CGH & SingHealth/NHG on incorporating licensed products into AIT Tech kiosk for deployment.
LuminiCell, a spin-off company from the National University of Singapore (NUS), has developed the next generation of bio imaging reagents based on the revolutionary Aggregation Induced Emission (AIE) technology.
Based on this breakthrough technology the company has already generated 4 products employing ultra bright fluorescence for cell- and vascular labelling (LuminiCell TrackerTM). LuminiCell TrackersTM give much higher brightness and significant longer tracking longevity compared to competitive products.
Funding: SPRING TECS POC and POV grants totaling S$750,000.
AITventures incubation services: Operations and production managers to establish and scale-up production and business development, incubation space, corporate secretary, financial-, admin- and HR support.
CardioGenomics a Singapore-based cardiogenetic testing company is already successfully capturing value from the rapidly growing genetic testing market.
CardioGenomics developed genetic assays to determine inherited cardiac conditions and lifetime risks for coronary heart disease specifically for the Asian population.
The company is currently processing customer samples based on NUHS lab protocols and algorithms and plans to further productize its products into test kits for the national and international market.
AITventures incubation services: Acting COO, support for business plan, product development and grant writing, providing incubation space, corporate secretary, financial, admin and HR support. Secured partnership with Malaysian distributor
